Share and Cite: Hinz, B. and Kenyon, J. (2025) Getting to a Diagnosis: A Rare Case of TFE3 Translocation Renal Cell Carcinoma ...
Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers ...
Trusted source of information on Respiratory Disorders that includes articles, news, videos, animations, quizzes, calculators and drugs.
Claudia Coll, 18, was born with cystic fibrosis and has been in and out of hospitals her whole life. Her brother Jordan, now 13, also has the debilitating condition. But things took a turn for the ...
CMTX-101 is under clinical development by Clarametyx Biosciences and currently in Phase II for Cystic Fibrosis. According to GlobalData, Phase II drugs for Cystic Fibrosis have a 31% phase transition ...
Cystic fibrosis, a genetic disease that attacks the lungs, affects roughly 1 in 3,000 people, and cystic fibrosis-related diabetes (CFRD) is its most common complication, a rare and unique type ...
X-rays, CT scans, and MRI – you may have had at least one of these tests done during your lifetime. While an X-ray may be sufficient in some instances, others may necessitate a CT scan or MRI. Each ...
This initiative bridges the gap by developing advanced AI tools to analyze images from calcium-scoring computed tomography (CT) scans ... engineering and radiology and Pingfu Fu, professor ...
A CT scan, or computed tomography scan, is a noninvasive medical imaging procedure that uses X-rays to create detailed pictures, typically used to see the inside of the body. A rare Kansas fossil ...
In December, the FDA approved Vertex’s vanzacaftor, tezacaftor and deutivacaftor (Alyftrek) for the treatment of cystic fibrosis in patients with at least one F508del mutation or another ...
KNEE3D, based at Norwich Research Park, is using state-of-the-art computed tomography (CT) scans to provide a 3D view of knee joints. Professor Tom Turmezei, the founder, says the technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results